To make adverse event data in clinical research consistent, attributable and traceable to its source, so the same evidence serves the investigator, the sponsor and the regulator from a drug's first-in-human trial through postmarket surveillance. In practice that means one engine grades, attributes and codes every adverse event the same way at every site, shows the reasoning behind each suggestion, and keeps the clinician as the person who decides. For research sites the aim is capacity: more trials with the same research team. For sponsors it is attribution that holds from the first trial to the label.
Interactive demo
Try Burna right now, no sign up required.